Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency at 10–14 weeks of gestation.Ultrasound Obstet Gynecol. 1998; 11: 391-400
- Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester.Ultrasound Obstet Gynecol. 2001; 18: 9-17
- Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses.Ultrasound Obstet Gynecol. 2001; 17: 102-105
- Increased nuchal translucency with normal karyotype.Am J Obstet Gynecol. 2005; 192: 1005-1021
- Increased nuchal translucency at 10–14 weeks of gestation as a marker for major cardiac defects.Ultrasound Obstet Gynecol. 1997; 10: 242-246
- Using fetal nuchal translucency to screen for major congenital heart defects at 10–14 weeks gestation: population based cohort study.BMJ. 1999; 318: 81-85
- Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype.Ultrasound Obstet Gynecol. 2001; 18: 610-614
- Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype.Ultrasound Obstet Gynecol. 2005; 26: 154-157
- Nuchal translucency and the risk of congenital heart disease.Obstet Gynecol. 2007; 109: 376-383
- Structural heart defects associated with an increased nuchal translucency: 9 years experience in a referral center.Prenat Diagn. 2008; 28: 347-354
- Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency.BJOG. 1999; 106: 829-833
American College of Obstetricians and Gynecologists (ACOG). Screening for fetal chromosomal abnormalities. ACOG Practice Bulletin No. 77. Washington, DC: American College of Obstetricians and Gynecologists; 2007.
- Fetal cardiac scanning performed immediately following abnormal nuchal translucency examination.Prenat Diagn. 2008; 28: 934-938
- Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.Ultrasound Obstet Gynecol. 2008; 31: 256-260
- Fetal hydrops secondary to human parvovirus infection in early pregnancy.Prenat Diagn. 1996; 16: 342-344
- Parvoviral infection associated with increased nuchal translucency: a case report.J Perinatol. 2000; 20: 129-131
- Fetal hydrops in the first trimester associated with maternal parvovirus infection.J Clin Ultrasound. 1998; 26: 314-316
- Parvovirus as a differential diagnosis of hydrops fetalis in the first trimester.Fetal Diagn Ther. 2000; 15: 234-236
- Increased fetal nuchal translucency thickness at 10–14 weeks: is screening for maternal-fetal infection necessary?.BJOG. 1997; 104: 212-215
- Outcome of fetuses with enlarged nuchal translucency and normal karyotype.Ultrasound Obstet Gynecol. 1998; 11: 401-437
- Early amniocentesis and fetal nuchal translucency in women requesting karyotyping for advanced maternal age.Prenat Diagn. 1995; 15: 971-974
- Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.Ultrasound Obstet Gynecol. 1995; 5: 15-19
- First-trimester diagnosis of nuchal anomalies: significance and fetal outcome.Ultrasound Obstet Gynecol. 1992; 2: 314-316
- Nuchal thickening or cystic hygromas in first- and early second-trimester fetuses: prognosis and outcome.Obstet Gynecol. 1993; 82: 43-48
- Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype.Prenat Diagn. 2002; 22: 345-349
- Bilateral cleft lip and palate associated with increased nuchal translucency and maternal cocaine abuse at 14 weeks of gestation.Clin Exp Obstet Gynecol. 2003; 30: 109-110
- Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10–14 weeks' gestation.Ultrasound Obstet Gynecol. 1998; 11: 407-409
- Pregnancy outcome and prognosis in fetuses with increased first-trimester nuchal translucency.Fetal Diagn Ther. 2001; 16: 360-363
- Fetal nuchal translucency thickness at 10–14 weeks of gestation and congenital diaphragmatic hernia.Obstet Gynecol. 1997; 90: 943-947
- Congenital diaphragmatic hernia. Two cases with early prenatal diagnosis and increased nuchal translucency.Fetal Diagn Ther. 2003; 18: 33-35
- Increased first-trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population.Br J Radiol. 1999; 72: 457-460
- Fetal outcome in nuchal translucency with emphasis on normal fetal karyotype.Prenat Diagn. 1996; 16: 537-541
- Fetal exomphalos at 11–14 weeks of gestation.J Ultrasound Med. 1995; 14: 569-574
- First trimester sonography of physiological midgut herniation and early diagnosis of omphalocele.Prenat Diagn. 1997; 17: 511-518
- Omphalocele-exstrophy-imperforate anus-spinal defects (OEIS) complex associated with increased nuchal translucency.Ultrasound Obstet Gynecol. 2003; 22: 95-97
- Fetal exomphalos and chromosomal defects: relationship to maternal age and gestation.Ultrasound Obstet Gynecol. 1995; 6: 250-255
- First-trimester simple hygroma: cause and outcome.Am J Obstet Gynecol. 1993; 168: 156-161
- The natural history of euploid pregnancies with first trimester cystic hygromas.Am J Obstet Gynecol. 1994; 170: 1279-1284
- Pregnancy outcome and infant follow-up of fetuses with abnormally increased first trimester nuchal translucency.Hum Reprod. 2000; 15: 2023-2027
- First trimester diagnosis of cystic hygroma; course and outcome.Am J Obstet Gynecol. 1992; 167: 94-98
- Fetal megacystis at 10–14 weeks of gestation.Ultrasound Obstet Gynecol. 1996; 8: 387-390
- Early fetal megacystis between 11 and 15 weeks of gestation.Ultrasound Obstet Gynecol. 1999; 14: 402-406
- Megacystis at 10–14 weeks of gestation: chromosomal defects and outcome according to bladder length.Ultrasound Obstet Gynecol. 2003; 21: 338-341
- First trimester isolated fetal nuchal lucency: significance and outcome.J Ultrasound Med. 1997; 16: 101-105
- Nuchal translucency in the first trimester.Aust N Z J Obstet Gynaecol. 1993; 33: 389-391
- Transvaginal ultrasound recognition of nuchal oedema in the first-trimester diagnosis of achondrogenesis.J Clin Ultrasound. 1991; 19: 586-590
- Achondrogenesis type 2 diagnosed by transvaginal ultrasound at 12 weeks of gestation.Prenat Diagn. 1993; 13: 523-528
- Achondrogenesis type I diagnosed by transvaginal ultrasonography at 13 weeks' gestation.Am J Obstet Gynecol. 1995; 173: 1620-1622
- Early sonographic diagnosis of Jarcho-Levin syndrome: a prospective screening program in one family.Ultrasound Obstet Gynecol. 1997; 9: 314-318
- Prenatal sonographic features of spondylocostal dysostosis and diaphragmatic hernia in the first trimester.Ultrasound Obstet Gynecol. 1999; 13: 213-215
- Detection of Jarcho-Levin syndrome at 12 weeks' gestation by nuchal translucency screening and three-dimensional ultrasound.Prenat Diagn. 2001; 21: 390-394
- Early diagnosis of a fetal skeletal dysplasia associated with increased nuchal translucency with 2D and 3D ultrasound.Ultraschall Med. 2003; 24: 349-352
- Lethal congenital arthrogryposis presents with increased nuchal translucency at 10–14 weeks of gestation.Ultrasound Obstet Gynecol. 1997; 9: 310-313
- Sonographic and maternal serum screening abnormalities in fetuses affected by spinal muscular atrophy.Prenat Diagn. 1997; 17: 166-169
- The association of increased fetal nuchal translucency and spinal muscular atrophy type I.Prenat Diagn. 1999; 19: 587-589
- The association of spinal muscular atrophy type II and increased nuchal translucency.Ultrasound Obstet Gynecol. 2002; 19: 312-313
- Beta-glucuronidase deficiency as cause of recurrent hydrops fetalis: the first early prenatal diagnosis by chorionic villus sampling.Prenat Diagn. 1998; 18: 959-962
- In-utero diagnosis of mucopolysaccharidosis type VII in a fetus with an enlarged nuchal translucency.Ultrasound Obstet Gynecol. 2000; 16: 87-90
- Mucopolysaccharidosis VII (Sly disease) as a cause of increased nuchal translucency and non-immune fetal hydrops: study of a family and technical approach to prenatal diagnosis in early and late pregnancy.Prenat Diagn. 2002; 22: 493-495
- Transvaginal sonography and transabdominal embryoscopy in the first-trimester diagnosis of Smith-Lemli-Opitz syndrome, type 2.Am J Obstet Gynecol. 1994; 171: 546-549
- Increased first trimester nuchal translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome.Am J Med Genet. 1995; 58: 374-376
- First trimester diagnosis of Smith-Lemli-Opitz syndrome.Prenat Diagn. 1997; 17: 355-361
- Enlarged nuchal translucency and low serum protein concentration as possible markers for Zellweger syndrome.Ultrasound Obstet Gynecol. 1999; 13: 268-270
- First trimester nuchal anomalies as a prenatal sign of Zellweger syndrome.Prenat Diagn. 2000; 20: 517-525
- First-trimester increased nuchal translucency and fetal hypokinesia associated with Zellweger syndrome.Ultrasound Obstet Gynecol. 2001; 17: 344-346
- Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening.Int J Gynaecol Obstet. 2004; 84: 5-9
- Body stalk anomaly at 10–14 weeks of gestation.Ultrasound Obstet Gynecol. 1997; 10: 416-418
- Prenatal ultrasound diagnosis and management of body stalk anomaly: analysis of nine singleton and two multiple pregnancies.Ultrasound Obstet Gynecol. 2003; 21: 322-328
- Fetal nuchal translucency and normal chromosomes: a long-term follow-up study.Ultrasound Obstet Gynecol. 2001; 18: 18-22
- Noonan syndrome: a cryptic condition in early gestation.Am J Med Genet. 2000; 92: 159-165
- Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.Ultrasound Obstet Gynecol. 2007; 30: 11-18
- Outcome of chromosomally normal live births with increased fetal nuchal translucency at 10–14 weeks' gestation.J Med Genet. 1998; 35: 222-224
- Performing a fetal anatomy scan at the time of first-trimester screening.Obstet Gynecol. 2009; 113: 402-407
- Screening for fetal anomalies during the first trimester of pregnancy: transvaginal versus transabdominal sonography.Ultrasound Obstet Gynecol. 1991; 1: 186-191
- Detection of fetal structural abnormalities at the 11–14 week ultrasound scan.Prenat Diagn. 2002; 22: 1-4
- Ultrasound detection of fetal anomalies in conjunction with first-trimester nuchal translucency screening: a feasibility study.Am J Obstet Gynecol. 2005; 193: 1260-1265
- First trimester pregnancy scanning as a screening tool for high-risk and abnormal pregnancies in a district general hospital setting.J Obstet Gynaecol. 2002; 22: 159-165
- First-trimester echogenic amniotic fluid in the acrania-anencephaly sequence.J Ultrasound Med. 2003; 22: 1075-1079
- First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications.BJOG. 2000; 107: 1265-1270
- Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss.Obstet Gynecol. 2004; 104: 30-36
- Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers.Am J Obstet Gynecol. 2008; 199 (e1–6): 290
- First trimester predictors of adverse pregnancy outcomes.Aust N Z J Obstet Gynaecol. 2008; 48: 529-535
- Pregnancy outcome in the setting of extremely low first trimester PAPP-A levels.Aust N Z J Obstet Gynaecol. 2009; 49: 258-262
- First-trimester placentation and the risk of antepartum stillbirth.JAMA. 2004; 292: 2249-2254
- Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth.J Clin Endocrinol Metab. 2002; 87: 1762-1767
- First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses.Ultrasound Obstet Gynecol. 2008; 31: 15-19
- Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes.Am J Obstet Gynecol. 2004; 191: 1452-1458
- First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.Ultrasound Obstet Gynecol. 2008; 31: 147-152
- Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome.Obstet Gynecol. 2006; 107: 161-166
- Second-trimester fetal growth as a predictor of poor obstetric and neonatal outcome in patients with low first-trimester serum pregnancy-associated plasma protein-A and a euploid fetus.Ultrasound Obstet Gynecol. 2009; 33: 34-38
- The predictive value of 18 and 22 week uterine artery Doppler in patients with low first trimester maternal serum PAPP-A.Prenat Diagn. 2009; 29: 248-252
- Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation.Prenat Diagn. 2008; 28: 1110-1115
- Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.Prenat Diagn. 2005; 25: 949-953
- First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia.Ultrasound Obstet Gynecol. 2009; 33: 23-33
- Maternal plasma inhibin A at 11–13 weeks of gestation in hypertensive disorders of pregnancy.Prenat Diagn. 2009; 29: 753-760
- A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound.Ultrasound Obstet Gynecol. 2006; 27: 13-17
- First-trimester prediction of hypertensive disorders in pregnancy.Hypertension. 2009; 53: 812-818
- Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two-vessel cord, and hydrocele.Prenat Diagn. 2008; 28: 1204-1208
- First-trimester maternal serum screening and the risk for fetal distress during labor.Am J Obstet Gynecol. 2009; 201 (e1–6): 166
Article info
Footnotes
No reprints will be available.
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
